kynurenine 3-monooxygenase inhibitors (MindImmune Therapeutics)

N/A

Report date: 2025/03/20 16:13:03
NME

Base Information

Drug Namekynurenine 3-monooxygenase inhibitors (MindImmune Therapeutics)
Drug Alias NameKMO inhibitors (MindImmune Therapeutics)kynurenine 3-monooxygenase inhibitors (Lundbeck/PsychoGenics)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionKynurenine 3-monooxygenase inhibitors
TargetsKynurenine 3-monooxygenase
Therapy Area/IndicationsHuntington DiseaseCentral Nervous System Diseases
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryUnited States
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaN/A
Originator CompaniesPsychoGenics Inc
China Registration ClassN/A

Develop Information

Active CompaniesMindImmune Therapeutics Inc
Inactive CompaniesLundbeck Research Usa IncPsychoGenics Inc
Active IndicationsHuntington Disease
Inactive IndicationsCentral Nervous System Diseases

Other Information

ATC CodeN/A
Related LinksN/A